Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib

BACKGROUND: Currently, there are no data available on the best choice of treatment in heavily pretreated patients with advanced breast cancer. However, the combination of oral vinorelbine and capecitabine has been demonstrated to be effective and safe in patients with advanced breast cancer pretreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sgroi, V., Bassanelli, M., Roberto, M., Iannicelli, E., Porrini, R., Pellegrini, P., Tafuri, A., Marchetti, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784669/
https://www.ncbi.nlm.nih.gov/pubmed/29416938
http://dx.doi.org/10.1186/s40164-018-0094-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784669/
https://www.ncbi.nlm.nih.gov/pubmed/29416938
http://dx.doi.org/10.1186/s40164-018-0094-9

Ejemplares similares